Stock Quote
Lannett Co Inc (LCI) (American Stock Exchange)
$6.10
10:06am EST
-4.69%
$6.40
$6.26
21,612
$6.29
$6.06
$9.74
$1.50
0.70
56,616
LCI
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Farber, William | Chairman of the Board | 44,000 |
| Bedrosian, Arthur | President, Chief Executive Officer, Director | 899,518 |
| West, Ronald | Vice Chairman of the Board | -- |
Profile
Lannett Company, Inc. (Lannett) develops, manufactures, markets and distributes generic versions of pharmaceutical products. The Company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order... Full Description
Company Address
Lannett Co Inc
9000 State Road
Philadelphia PA 19136
P: +1215.3339000
9000 State Road
Philadelphia PA 19136
P: +1215.3339000
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Watson Pharmaceuticals, Inc. | $35.86 | +0.71 |
| GlaxoSmithKline plc | £1,285.00 | +31.50 |
| Caraco Pharmaceutical Laboratories Ltd. | $4.18 | +0.08 |
| LCI | Industry | |
|---|---|---|
| P/E(TTM) | 24.16 | 3.57 |
| P/S(TTM) | 1.32 | 0.57 |
| ROI(TTM) | 8.03 | 1.86 |
| ROE(TTM) | 8.90 | 2.51 |
No consensus estimates data available.
| Total Revenue | $35.45M |
| Net Income | $2.42M |
| EPS | $0.10 |
